| [1] |
Yoshida K,Toki F,Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. proposal of the concept of autoimmune pancreatitis[J]. Dig Dis Sci, 1995, 40(7):1561-1568.
|
| [2] |
Okazaki K,Kawa S,Kamisawa T, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 I. concept and diagnosis of autoimmune pancreatitis[J]. J Gastroenterol, 2014, 49(4):567-588.
|
| [3] |
Khosroshahi A,Wallace ZS,Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7):1688-1699.
|
| [4] |
Okazaki K,Chari ST,Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis[J]. Pancreatology, 2017, 17(1):1-6.
|
| [5] |
Uchida K,Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis[J]. J Gastroenterol, 2018, 53(4):475-483.
|
| [6] |
Nagpal SJS,Sharma A,Chari ST. Autoimmune pancreatitis[J]. Am J Gastroenterol, 2018, 113(9):1301-1309.
|
| [7] |
Tsen A,Alishahi Y,Rosenkranz L. Autoimmune pancreatitis and inflammatory bowel disease: an updated review[J]. J Clin Gastroenterol, 2017, 51(3):208-214.
|
| [8] |
Sah RP,Chari ST. Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management[J]. Curr Gastroenterol Rep, 2012, 14(2):95-105.
|
| [9] |
Meng Q,Xin L,Liu W, et al. Diagnosis and treatment of autoimmune pancreatitis in China: a systematic review[J]. PLoS One, 2015, 10(6): e0130466.
|
| [10] |
Kamisawa T,Zen Y,Nakazawa T, et al. Advances in IgG4-related pancreatobiliary diseases[J]. Lancet Gastroenterol Hepatol, 2018, 3(8):575-585.
|
| [11] |
Morselli-Labate AM,Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis[J]. J Gastroenterol Hepatol, 2009, 24(1):15-36.
|
| [12] |
Yan T,Ke Y,Chen Y, et al. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin[J]. PLoS One, 2017, 12(4):e0174735.
|
| [13] |
Gu X,Liu R. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly[J]. Clin Interv Aging, 2016(11):1365-1370.
|
| [14] |
Sandrasegaran K,Menias CO. Imaging in autoimmune pancreatitis and immunoglobulin G4-related disease of the abdomen[J]. Gastroenterol Clin North Am, 2018, 47(3):603-619.
|
| [15] |
Kim M,Jang KM,Kim JH, et al. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping[J]. Eur Radiol, 2017, 27(4):1722-1732.
|
| [16] |
Yadav AK,Sharma R,Kandasamy D, et al. Perfusion CT-can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?[J]. Pancreatology, 2016, 16(6):979-987.
|
| [17] |
Zhang TT,Wang L,Liu HH, et al. Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging[J]. Oncotarget, 2017, 8(1):1744-1759.
|
| [18] |
Kim JH,Byun JH,Kim MH, et al. Pancreatic duct in autoimmune pancreatitis: intraindividual comparison of magnetic resonance pancreatography at 1.5 T and 3.0 T[J]. Pancreas, 2017, 46(7):921-926.
|
| [19] |
Niu XK,Bhetuwal A,Das S, et al. Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses[J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(6):950-956.
|
| [20] |
Dong A,Dong H,Zhang L, et al. Hypermetabolic lesions of the pancreas on FDG PET/CT[J]. Clin Nucl Med, 2013, 38(9):e354-366.
|
| [21] |
Kato K,Nihashi T,Ikeda M, et al. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis[J]. Clin Nucl Med, 2013, 38(6):417-421.
|
| [22] |
Zhang J,Jia G,Zuo C, et al. 18F-FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer[J]. BMC Cancer, 2017, 17(1):695.
|
| [23] |
Cheng MF,Guo YL,Yen RF, et al. Clinical utility of FDG PET/CT in patients with autoimmune pancreatitis: a case-control study[J]. Sci Rep, 2018, 8(1):3651.
|
| [24] |
Fujii-Lau LL,Levy MJ. The role of endoscopic ultrasound in the diagnosis of autoimmune pancreatitis[J]. Gastrointest Endosc Clin N Am, 2017, 27(4):643-655.
|
| [25] |
Kamisawa T,Yoshiike M,Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study[J]. Pancreatology, 2005, 5(2/3):234-238.
|
| [26] |
Park MK,Jo J,Kwon H, et al. Usefulness of acoustic radiation force impulse elastography in the differential diagnosis of benign and malignant solid pancreatic lesions[J]. Ultrasonography, 2014, 33(1): 26-33.
|
| [27] |
Detlefsen S,Mortensen MB,Pless TK, et al. Laparoscopic and percutaneous core needle biopsy plays a central role for the diagnosis of autoimmune pancreatitis in a single-center study from Denmark[J]. Pancreas, 2015, 44(6):845-858.
|
| [28] |
Sugimoto M,Takagi T,Suzuki R, et al. Endoscopic ultrasonography-guided fine needle aspiration can be used to rule out malignancy in autoimmune pancreatitis patients[J]. J Ultrasound Med, 2017, 36(11): 2237-2244.
|
| [29] |
Ghazale A,Chari ST,Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy[J]. Gastroenterology, 2008, 134(3):706-715.
|
| [30] |
Kanno A,Masamune A,Fujishima F, et al. Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: a prospective multicenter study[J]. Gastrointest Endosc, 2016, 84(5): 797-804, e1.
|
| [31] |
Sugumar A,Levy MJ,Kamisawa T, et al. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study[J]. Gut, 2011, 60(5):666-670.
|
| [32] |
Kamisawa T,Okazaki K,Kawa S, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 III. treatment and prognosis of autoimmune pancreatitis[J]. J Gastroenterol, 2014, 49(6):961-970.
|
| [33] |
Buijs J,van Heerde MJ,Rauws EA, et al. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis[J]. Pancreas, 2014, 43(2):261-267.
|
| [34] |
Kamisawa T,Shimosegawa T,Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis[J]. Gut, 2009, 58(11):1504-1507.
|
| [35] |
Hart PA,Topazian MD,Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience[J]. Gut, 2013, 62(11):1607-1615.
|
| [36] |
Hart PA,Kamisawa T,Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis[J]. Gut, 2013, 62(12):1771-1776.
|
| [37] |
Witkiewicz AK,Kennedy EP,Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature[J]. Hum Pathol, 2008, 39(10):1548-1551.
|
| [38] |
Ito T,Nakamura T,Fujimori N, et al. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis[J]. J Dig Dis, 2011, 12(3):210-216.
|
| [39] |
Lin YK,Johnston PC,Arce K, et al. Chronic pancreatitis and diabetes mellitus[J]. Curr Treat Options Gastroenterol, 2015, 13(3):319-331.
|
| [40] |
Working Party of the Australasian Pancreatic Club, Smith RC,Smith SF, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency[J]. Pancreatology, 2016, 16(2):164-180.
|